Avricore Health (AVCRF) Current Leases (2010 - 2019)

Avricore Health (AVCRF) posted quarterly Current Leases of $16202.9 for Q4 2019, down 98.13% quarter-over-quarter from $866903.1 in Q2 2012.

Avricore Health (AVCRF) Current Leases (2010 - 2019) Analysis & Trends

Avricore Health (AVCRF) has reported Current Leases for 4 consecutive years, with $16202.9 the latest figure, recorded in Q4 2019.

In Q4 2019, Current Leases changed N/A year-over-year to $16202.9; the TTM figure through Dec 2019 stood at $16202.9 (changed N/A YoY), while the FY2019 annual figure was $16121.2, changed N/A from the prior year.
Current Leases slipped to $16202.9 in Q4 2019 per AVCRF's latest filing, from $866903.1 in the prior quarter.
Across five years, Current Leases topped out at $16202.9 in Q4 2019 and bottomed at $16202.9 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Thermo Fisher Scientific	213.40 Bn	209.33 Bn	8.34 Bn	-
2	Danaher	139.94 Bn	135.59 Bn	3.61 Bn	-
3	Idexx Laboratories	46.03 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.69 Bn	37.88 Bn	990.00 Mn	-
5	Iqvia Holdings	39.32 Bn	37.24 Bn	1.44 Bn	-
6	Natera	38.47 Bn	37.37 Bn	696.04 Mn	-
7	Illumina	29.98 Bn	28.82 Bn	770.00 Mn	-
8	Mettler Toledo International	28.57 Bn	28.52 Bn	650.22 Mn	-
9	Quest Diagnostics	26.21 Bn	25.58 Bn	1.03 Bn	180.00 Mn
10	Avricore Health	3.04 Mn	3.01 Mn	-6,202.70	-

Download Data